Changes in the pattern of paracetamol use in the periconception period in a Danish cohort

Anne S Ersbøll1,2, Mette Hedegaard1,2, Peter Damm2,3

  • 1Research Unit, Women's and Children's Health, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.

Insights

Paracetamol is a common pregnancy medication. Frequent use before and during early pregnancy was linked to factors like smoking and unplanned pregnancies, with usage decreasing after legislation restricted large pack access.

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology
  • Public Health

Background:

  • Paracetamol (acetaminophen) is a widely used over-the-counter medication during pregnancy.
  • While generally considered safe, prolonged antenatal exposure is linked to potential offspring morbidity.
  • Understanding usage patterns, especially frequent use, is crucial for maternal and child health.

Purpose of the Study:

  • To characterize paracetamol (acetaminophen) consumption patterns in pregnant women.
  • To identify factors associated with frequent paracetamol use (more than once weekly) before and during early pregnancy.
  • To evaluate the impact of legislation restricting large pack access on paracetamol usage.

Main Methods:

  • A web-based clinical questionnaire administered to 8650 pregnant women.
  • Data collected on drug use, including paracetamol, in the 3 months prior to and during early pregnancy.
  • Statistical analysis to identify associations between frequent paracetamol use and demographic/clinical factors.

Main Results:

  • Paracetamol was the most frequently used drug, with 35.2% use before pregnancy and 6.5% during early pregnancy.
  • The proportion of frequent paracetamol users decreased from 3.9% pre-pregnancy to 0.9% in early pregnancy.
  • Frequent use was associated with smoking, comorbidities, higher BMI, unplanned pregnancy, lower education, and language barriers. Legislation restricting large pack access correlated with a decrease in overall paracetamol use.

Conclusions:

  • Paracetamol is commonly used by pregnant women, but frequent use is less common and associated with specific risk factors.
  • Legislation limiting access to large paracetamol packs may reduce overall usage during pregnancy.
  • Further research into the specific risks of frequent antenatal paracetamol exposure is warranted.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
353
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
896
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
943